Download Free Sample Report

Infertility Drugs Market, Global Outlook and Forecast 2023-2029

Infertility Drugs Market, Global Outlook and Forecast 2023-2029

  • Published on : 22 March 2023
  • Pages :62
  • Report Code:SMR-7609291

Download Report PDF Instantly

Leave This Empty:

Secure

Report overview

Infertility Drugs are drugs which enhance reproductive fertility. For women, Infertility Drugs is used to stimulate follicle development of the ovary. Agents that enhance ovarian activity can be classified as either Gonadotropin releasing hormone, Estrogen antagonists or Gonadotropins.
This report aims to provide a comprehensive presentation of the global market for Infertility Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Infertility Drugs. This report contains market size and forecasts of Infertility Drugs in global, including the following market information:
Global Infertility Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Infertility Drugs market was valued at US$ 5313.5 million in 2022 and is projected to reach US$ 7560.7 million by 2029, at a CAGR of 5.2% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global Infertility Drugs key players include LIVZON, Merck, Abbott, Ferring, etc. Global top four manufacturers hold a share about 45%.
North America is the largest market, with a share about 45%, followed by Europe, and Asia-Pacific, both have a share about 35 percent.
In terms of product, Gonadotropins is the largest segment, with a share nearly 80%. And in terms of application, the largest application is Female, followed by Male.
We surveyed the Infertility Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Infertility Drugs Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Infertility Drugs Market Segment Percentages, by Type, 2022 (%)
Gonadotropins
Anti-Estrogens
Other
Global Infertility Drugs Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Infertility Drugs Market Segment Percentages, by Application, 2022 (%)
Male
Female
Global Infertility Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Infertility Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Infertility Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Infertility Drugs revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck
Ferring
MSD
LIVZON
Abbott
Bayer Zydus Pharma
Outline of Major Chapters:
Chapter 1: Introduces the definition of Infertility Drugs, market overview.
Chapter 2: Global Infertility Drugs market size in revenue.
Chapter 3: Detailed analysis of Infertility Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Infertility Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.